Perimenopause — the transitional phase leading up to menopause — typically begins in a woman's mid-to-late 40s and lasts 4–10 years. During perimenopause, oestrogen and progesterone fluctuate erratically, causing irregular menstrual cycles, hot flushes, night sweats, mood instability, anxiety, sleep disruption, and cognitive changes. Supplements that support hormonal stability, HPA axis regulation, and neurotransmitter balance are most relevant during this phase.
Best Supplements for Perimenopause
We assessed each supplement for clinical evidence quality, mechanism of action, dosing transparency, and safety. Evidence grades: A = strong RCT evidence; B = good clinical evidence; C = preliminary or emerging evidence.
Addresses multiple perimenopause symptoms: sleep disruption (GABA modulation), anxiety (HPA axis regulation), mood instability, and migraine frequency (which increases during hormonal fluctuation). Oestrogen fluctuations reduce magnesium retention. Evening magnesium glycinate is one of the most practical and effective single supplements for perimenopausal symptom management.
An RCT in perimenopausal and menopausal women found KSM-66 (300 mg twice daily) significantly reduced hot flushes, anxiety, mood symptoms, and sleep difficulties vs placebo. By modulating HPA axis cortisol output — which is dysregulated during perimenopause — ashwagandha helps stabilise hormonal rhythms and improve stress resilience during this transition.
Bone density begins declining during perimenopause as oestrogen starts falling. Starting D3+K2 during perimenopause is more protective than starting after menopause. D3 maintains calcium absorption; K2 activates bone-protective osteocalcin. Also supports mood stability through vitamin D's neurological roles.
EPA-dominant omega-3 reduces the inflammatory component of perimenopausal mood changes, supports serotonin signalling (relevant to mood and hot flush pathways), and provides early cardiovascular protection before the full post-menopausal risk increase. DHA supports cognitive function during the perimenopausal brain fog phase.
Saffron has emerging but compelling RCT evidence for perimenopausal mood symptoms — specifically anxiety, low mood, and sexual dysfunction. Acts through serotonin reuptake inhibition (similar mechanism to SSRIs but at much lower potency). Multiple RCTs show 30 mg/day affron® saffron extract improves mood scores significantly vs placebo.
Melatonin production declines with age, contributing to perimenopausal sleep disruption. Melatonin also has direct effects on the hypothalamic-pituitary-ovarian axis — some evidence suggests it may help maintain ovarian function during early perimenopause. Use the lowest effective dose (0.3–1 mg) to avoid morning grogginess.
⚠ Safety & Medical Disclaimer
Perimenopausal symptoms can significantly impact quality of life — if severe, hormone replacement therapy (HRT) or low-dose hormonal contraception may be more appropriate than supplements alone. Discuss symptom severity with a gynaecologist. Saffron at very high doses (>5 g whole saffron) can be toxic — use only standardised extracts at recommended doses.
Frequently Asked Questions
Clinical References
All supplement recommendations are supported by peer-reviewed research. Key citations:
- Anahita Farzaneh M et al. (2017). Nutrients. The relationship between magnesium deficiency and menopausal symptoms. → Source
- Nuñez-González S et al. (2019). Nutrients. Effectiveness of omega-3 supplementation in menopausal transition. → Source
- Lopresti AL et al. (2019). Menopause. An investigation into an evening primrose oil and ashwagandha combination. → Source